Literature DB >> 2569567

Single treatment of invasive fascioliasis with triclabendazole.

L Loutan, M Bouvier, B Rojanawisut, H Stalder, M C Rouan, G Buescher, A A Poltera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2569567     DOI： 10.1016/s0140-6736(89)90557-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Acute Fasciola hepatica infection attributed to chewing khat.

Authors:  A Cats; P Scholten; S G Meuwissen; E J Kuipers
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  Praziquantel failure in the treatment of Fasciola hepatica.

Authors:  D M Patrick; J Isaac-Renton
Journal:  Can J Infect Dis       Date:  1992-01

3.  Human infection with Dicrocoelium dendriticum in Turkey.

Authors:  Zeynep Tas Cengiz; Hasan Yilmaz; Ahmet Cumhur Dulger; Mutalip Cicek
Journal:  Ann Saudi Med       Date:  2010 Mar-Apr       Impact factor: 1.526

4.  Fasciola hepatica infestation as a very rare cause of extrahepatic cholestasis.

Authors:  Ahmet Dobrucali; Rafet Yigitbasi; Yusuf Erzin; Oguzhan Sunamak; Erdal Polat; Hakan Yakar
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

5.  Effect of food on the bioavailability of triclabendazole in patients with fascioliasis.

Authors:  J B Lecaillon; J Godbillon; J Campestrini; C Naquira; L Miranda; R Pacheco; R Mull; A A Poltera
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

6.  The small molecule triclabendazole decreases the intracellular level of cyclic AMP and increases resistance to stress in Saccharomyces cerevisiae.

Authors:  Yong Joo Lee; Runhua Shi; Stephan N Witt
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.